We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$273M
Cap. Flow %
1.9%
Top 10 Hldgs %
37.21%
Holding
1,342
New
30
Increased
738
Reduced
241
Closed
27

Sector Composition

Rank Sector Weight
1 Real Estate 55.05%
2 Technology 11.48%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRMY icon
1101
Harmony Biosciences
HRMY
$2.08B
$8K ﹤0.01%
239
IMVT icon
1102
Immunovant
IMVT
$7.93B
$8K ﹤0.01%
520
KRYS icon
1103
Krystal Biotech
KRYS
$10.7B
$8K ﹤0.01%
96
MYGN icon
1104
Myriad Genetics
MYGN
$476M
$8K ﹤0.01%
326
RLAY icon
1105
Relay Therapeutics
RLAY
$4B
$8K ﹤0.01%
486
RVMD icon
1106
Revolution Medicines
RVMD
$38.5B
$8K ﹤0.01%
357
SUPN icon
1107
Supernus Pharmaceuticals
SUPN
$2.7B
$8K ﹤0.01%
217
VTYX
1108
DELISTED
Ventyx Biosciences
VTYX
$8K ﹤0.01%
228
PRVB
1109
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$8K ﹤0.01%
351
AKRO
1110
DELISTED
Akero Therapeutics
AKRO
$7K ﹤0.01%
188
AMPH icon
1111
Amphastar Pharmaceuticals
AMPH
$907M
$7K ﹤0.01%
194
KYNB
1112
Kyntra Bio
KYNB
$27.4M
$7K ﹤0.01%
15
KYMR icon
1113
Kymera Therapeutics
KYMR
$8.66B
$7K ﹤0.01%
221
MRVI icon
1114
Maravai LifeSciences
MRVI
$972M
$7K ﹤0.01%
490
PCRX icon
1115
Pacira BioSciences
PCRX
$1.04B
$7K ﹤0.01%
169
AUPH icon
1116
Aurinia Pharmaceuticals
AUPH
$1.95B
$6K ﹤0.01%
528
BCRX icon
1117
BioCryst Pharmaceuticals
BCRX
$2.42B
$6K ﹤0.01%
692
GMAB icon
1118
Genmab
GMAB
$17.5B
$6K ﹤0.01%
172
IRWD icon
1119
Ironwood Pharmaceuticals
IRWD
$586M
$6K ﹤0.01%
573
SWTX
1120
DELISTED
SpringWorks Therapeutics
SWTX
$6K ﹤0.01%
251
TVTX icon
1121
Travere Therapeutics
TVTX
$5.17B
$6K ﹤0.01%
258
VCYT icon
1122
Veracyte
VCYT
$4.45B
$6K ﹤0.01%
266
XNCR icon
1123
Xencor
XNCR
$1.45B
$6K ﹤0.01%
222
MORF
1124
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$6K ﹤0.01%
155
DICE
1125
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$6K ﹤0.01%
192

Similar funds

Daiwa Securities Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daiwa Securities Group held 1,342 positions worth $14.4B, up 10% from $13B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Daiwa Securities Group opened 30 new positions and exited 27, leaving the 1,342-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2023 buy was Global X Aging Population ETF: 800,000 shares worth $21.4M.
  • Daiwa Securities Group added most to VICI Properties in Q1 2023, an estimated $79.2M increase.
  • Daiwa Securities Group's biggest Q1 2023 reduction was Lamar Advertising Co, cutting an estimated $81.1M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $15.2M.
  • Daiwa Securities Group's ten largest holdings make up 37% of its $14.4B portfolio in Q1 2023.
  • Daiwa Securities Group opened 30 new positions and closed 27 in Q1 2023.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.